MedPath

Maternal moments

Not Applicable
Conditions
Antenatal anxiety and depression
Mental and Behavioural Disorders
Registration Number
ISRCTN11696836
Lead Sponsor
Goldsmiths, University of London
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped
Sex
Female
Target Recruitment
150
Inclusion Criteria

Mother inclusion criteria:
1. Have a computer or a smart phone at home
2. Referred by the clinical team
3. Fluent in English
4. Aged 18-45 years old
5. Singleton birth

Infant inclusion criteria:
1. Born after 37 weeks
2. Age 6 months
3. No major disability or medical disorder

Exclusion Criteria

Mother exclusion criteria:
1. Not enough time to dedicate to the study
2. Serious medical disorder, psychosis, bipolar disorder or drug abuse
3. If the baby is born before 37 weeks, is still born, or the mother has a miscarriage the mother will not be included in the study will be discontinued

Infant exclusion criteria:
1. Any medical disorder or major disability
2. Born before 37 weeks

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1. Depression is assessed using the Edinburgh Postnatal Depression Scale (EPDS) at 20 , 26 and 32 weeks, and 1, 3 and 6 months postnatal<br> 2. Anxiety is assessed using the Spielberger State and Trait Anxiety (STAI) at 20 , 26 and 32 weeks, and 1, 3 and 6 months postnatal and the Pregnancy-Related Anxiety Questionnaire Revised (PRAQ-R2) at 20, 26 and 32 weeks<br> 3. Stress is assessed using the Perceived Stress Scale (PSS) at 20 , 26 and 32 weeks, and 1, 3 and 6 months postnatal<br>
Secondary Outcome Measures
NameTimeMethod
<br> 1. Mother-infant attachment is assessed using the Mother Infant Bonding Scale (MIBS) at 1 and 3 months postnatal, the Maternal Antenatal Attachment Scale (MAAS) at 20, 26 and 32 weeks and the Maternal Postnatal Attachment Scale (MPAS) at 1, 3 and 6 months postnatal<br> 2. Infant cognitive and behavioural development is assessed using the Infant Behaviour Questionnaire revised (IBQ-R) and the Bayley Scales of Infant and Toddler Development (Bayley III) at when the child is 6 months old<br> 3. Biological changes in cortisol and various cytokines are measured using saliva samples at 0 weeks, 32 weeks and 6 months postnatal<br>
© Copyright 2025. All Rights Reserved by MedPath